OXA-48-Mediated Ceftazidime-Avibactam Resistance Is Associated with Evolutionary Trade-Offs
出版年份 2019 全文链接
标题
OXA-48-Mediated Ceftazidime-Avibactam Resistance Is Associated with Evolutionary Trade-Offs
作者
关键词
-
出版物
mSphere
Volume 4, Issue 2, Pages -
出版商
American Society for Microbiology
发表日期
2019-03-26
DOI
10.1128/msphere.00024-19
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A focused fragment library targeting the antibiotic resistance enzyme - Oxacillinase-48: Synthesis, structural evaluation and inhibitor design
- (2018) Sundus Akhter et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment
- (2018) Paolo Gaibani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- SWISS-MODEL: homology modelling of protein structures and complexes
- (2018) Andrew Waterhouse et al. NUCLEIC ACIDS RESEARCH
- Treatment of Infections with OXA-48 producing Enterobacteriaceae
- (2018) Adam Stewart et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Conserved collateral antibiotic susceptibility networks in diverse clinical strains of Escherichia coli
- (2018) Nicole L. Podnecky et al. Nature Communications
- Estimating the number of infections caused by antibiotic-resistant Escherichia coli and Klebsiella pneumoniae in 2014: a modelling study
- (2018) Elizabeth Temkin et al. Lancet Global Health
- Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis
- (2018) Alessandro Cassini et al. LANCET INFECTIOUS DISEASES
- OXA-48-like carbapenemases producing Enterobacteriaceae in different niches
- (2017) Assia Mairi et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Emergence of ceftazidime/avibactam non-susceptibility in an MDR Klebsiella pneumoniae isolate
- (2017) Anna Both et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Structure, activity and thermostability investigations of OXA-163, OXA-181 and OXA-245 using biochemical analysis, crystal structures and differential scanning calorimetry analysis
- (2017) Bjarte Aarmo Lund et al. Acta Crystallographica Section F-Structural Biology Communications
- Emergence of Ceftazidime-Avibactam Resistance and Restoration of Carbapenem Susceptibility in Klebsiella pneumoniae Carbapenemase-Producing K pneumoniae: A Case Report and Review of Literature
- (2017) Ryan K. Shields et al. Open Forum Infectious Diseases
- Molecular and epidemiological characterization of carbapenemase-producing Enterobacteriaceae in Norway, 2007 to 2014
- (2017) Ørjan Samuelsen et al. PLoS One
- Activity of Ceftazidime-Avibactam against Extended-Spectrum- and AmpC β-Lactamase-Producing Enterobacteriaceae Collected in the INFORM Global Surveillance Study from 2012 to 2014
- (2016) James A. Karlowsky et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Low Frequency of Ceftazidime-Avibactam Resistance among Enterobacteriaceae Isolates Carrying bla KPC Collected in U.S. Hospitals from 2012 to 2015
- (2016) Mariana Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne bla KPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections
- (2016) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections: Table 1.
- (2016) Ryan K. Shields et al. CLINICAL INFECTIOUS DISEASES
- Ceftazidime-Avibactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination for the Treatment of Resistant Gram-negative Organisms
- (2016) Roopali Sharma et al. CLINICAL THERAPEUTICS
- An in silico approach to elucidate structure based functional evolution of oxacillinase
- (2016) Arijit Pal et al. COMPUTATIONAL BIOLOGY AND CHEMISTRY
- New β-Lactamase Inhibitors in the Clinic
- (2016) Krisztina M. Papp-Wallace et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Screening and Design of Inhibitor Scaffolds for the Antibiotic Resistance Oxacillinase-48 (OXA-48) through Surface Plasmon Resonance Screening
- (2016) Bjarte Aarmo Lund et al. JOURNAL OF MEDICINAL CHEMISTRY
- One ring to rule them all: Current trends in combating bacterial resistance to the β-lactams
- (2016) Dustin T. King et al. PROTEIN SCIENCE
- Room temperature electrocompetent bacterial cells improve DNA transformation and recombineering efficiency
- (2016) Qiang Tu et al. Scientific Reports
- The global epidemiology of carbapenemase-producing Enterobacteriaceae
- (2016) David van Duin et al. Virulence
- Functional Trade-Offs in Promiscuous Enzymes Cannot Be Explained by Intrinsic Mutational Robustness of the Native Activity
- (2016) Miriam Kaltenbach et al. PLoS Genetics
- Multicopy plasmids potentiate the evolution of antibiotic resistance in bacteria
- (2016) Alvaro San Millan et al. Nature Ecology & Evolution
- Genetic and Biochemical Characterization of OXA-405, an OXA-48-Type Extended-Spectrum β-Lactamase without Significant Carbapenemase Activity
- (2015) Laurent Dortet et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- First Report of Ceftazidime-Avibactam Resistance in a KPC-3-Expressing Klebsiella pneumoniae Isolate
- (2015) Romney M. Humphries et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Potential of Tetracycline Resistance Proteins To Evolve Tigecycline Resistance
- (2015) Marius Linkevicius et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroSelection of Ceftazidime-Avibactam Resistance in Enterobacteriaceae with KPC-3 Carbapenemase
- (2015) David M. Livermore et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Structural Basis for Different Substrate Profiles of Two Closely Related Class D β-Lactamases and Their Inhibition by Halogens
- (2015) Vlatko Stojanoski et al. BIOCHEMISTRY
- Temporal variation in antibiotic environments slows down resistance evolution in pathogenicPseudomonas aeruginosa
- (2015) Roderich Roemhild et al. Evolutionary Applications
- Selection and molecular characterization of ceftazidime/avibactam-resistant mutants in Pseudomonas aeruginosa strains containing derepressed AmpC
- (2015) S. D. Lahiri et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA
- (2015) Patrick R Gonzales et al. Nature Chemical Biology
- The β-Lactams Strike Back: Ceftazidime-Avibactam
- (2015) Evan J. Zasowski et al. PHARMACOTHERAPY
- Molecular Mechanism of Avibactam-Mediated β-Lactamase Inhibition
- (2015) Dustin T. King et al. ACS Infectious Diseases
- His224 Alters the R2 Drug Binding Site and Phe218 Influences the Catalytic Efficiency of the Metallo-β-Lactamase VIM-7
- (2014) Hanna-Kirsti S. Leiros et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A high-throughput, restriction-free cloning and screening strategy based on ccdB-gene replacement
- (2014) Bjarte Lund et al. Microbial Cell Factories
- How good are my data and what is the resolution?
- (2013) Philip R. Evans et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Intrapatient emergence of OXA-247: a novel carbapenemase found in a patient previously infected with OXA-163-producing Klebsiella pneumoniae
- (2013) S. Gomez et al. CLINICAL MICROBIOLOGY AND INFECTION
- Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination
- (2013) George G. Zhanel et al. DRUGS
- Identification of Enterobacteriaceae isolates with OXA-48 and coproduction of OXA-181 and NDM-1 in Norway
- (2013) O. Samuelsen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Kinetics of Avibactam Inhibition against Class A, C, and D β-Lactamases
- (2013) David E. Ehmann et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Use of Collateral Sensitivity Networks to Design Drug Cycling Protocols That Avoid Resistance Development
- (2013) L. Imamovic et al. Science Translational Medicine
- “Stormy waters ahead”: global emergence of carbapenemases
- (2013) Gopi Patel et al. Frontiers in Microbiology
- OXA-48-like carbapenemases: the phantom menace
- (2012) L. Poirel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Avibactam is a covalent, reversible, non- -lactam -lactamase inhibitor
- (2012) D. E. Ehmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Carbapenem resistance in Enterobacteriaceae: here is the storm!
- (2012) Patrice Nordmann et al. TRENDS IN MOLECULAR MEDICINE
- Genetic Features of the Widespread Plasmid Coding for the Carbapenemase OXA-48
- (2011) Laurent Poirel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- OXA-163, an OXA-48-Related Class D β-Lactamase with Extended Activity Toward Expanded-Spectrum Cephalosporins
- (2011) Laurent Poirel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons
- (2011) Nabil-Fareed Alikhan et al. BMC GENOMICS
- European dissemination of a single OXA-48-producing Klebsiella pneumoniae clone
- (2011) A. Potron et al. CLINICAL MICROBIOLOGY AND INFECTION
- In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae
- (2011) Z. Aktaş et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Structural and Computational Investigations of VIM-7: Insights into the Substrate Specificity of VIM Metallo-β-Lactamases
- (2011) Pardha Saradhi Borra et al. JOURNAL OF MOLECULAR BIOLOGY
- XDS
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Emerging carbapenemases: a global perspective
- (2010) Timothy R. Walsh INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In Vitro Activity of NXL104 in Combination with -Lactams against Klebsiella pneumoniae Isolates Producing KPC Carbapenemases
- (2009) A. Endimiani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Crystal Structure of the OXA-48 β-Lactamase Reveals Mechanistic Diversity among Class D Carbapenemases
- (2009) Jean-Denis Docquier et al. CHEMISTRY & BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started